FDA Clears Inceptiv, a Closed-Loop Spinal Cord Stimulator for Chronic Pain
The Food and Drug Administration has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator to treat chronic pain.
Stay updated with breaking news from Pain Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator to treat chronic pain.
The Food and Drug Administration has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator to treat chronic pain.
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc , a global leader in healthcare...
Medtronic (NYSE: MDT) announced that it received FDA approval for the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) system.
Medtronic has received U.S. Food and Drug Administration (FDA) approval of its next-generation SynchroMed III intrathecal drug delivery system for patients with chronic pain, cancer pain, and severe spasticity. SynchroMed III is a targeted drug delivery (TDD) platform that alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III is an upgraded system compared to the SynchroMed II system, featuring a new "refill only" physician workflow for more efficient programming, improved electronics with firmware capable of being updated aft...